Table II.
Baseline | Post-intervention (at 3-months) | |||||||
---|---|---|---|---|---|---|---|---|
All subjects (n = 39) | Intervention (n = 22) | Control (n = 17) | P § | All subjects (n = 35) | Intervention (n = 20) | Control (n = 15) | P § | |
Plasma carotenoids and tocopherols (μg/ml) | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | ||
α–tocopherol | 14.91 ± 5.15 | 15.23 ± 5.56 | 14.51 ± 4.71 | 0.67 | 14.35 ± 5.17 | 14.64 ± 5.48 | 13.96 ± 4.87 | 0.71 |
γ–tocopherol | 1.70 ± 1.01 | 1.67 ± 1.01 | 1.73 ± 1.04 | 0.86 | 1.65 ± 0.99 | 1.60 ± 0.89 | 1.70 ± 1.13 | 0.78 |
α–carotene | 0.04 ± 0.03 | 0.04 ± 0.03 | 0.05 ± 0.03 | 0.60 | 0.05 ± 0.04 | 0.04 ± 0.03 | 0.05 ± 0.05 | 0.64 |
cis–β-carotene | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.07 | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.32 |
trans–β-carotene | 0.20 ± 0.13 | 0.18 ± 0.12 | 0.24 ± 0.15 | 0.17 | 0.20 ± 0.14 | 0.20 ± 0.16 | 0.21 ± 0.12 | 0.83 |
α–cryptoxanthin | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.77 | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.86 |
β–cryptoxanthin | 0.11 ± 0.08 | 0.11 ± 0.09 | 0.10 ± 0.07 | 0.71 | 0.10 ± 0.07 | 0.10 ± 0.08 | 0.09 ± 0.06 | 0.87 |
lutein | 0.11 ± 0.06 | 0.10 ± 0.06 | 0.12 ± 0.07 | 0.40 | 0.12 ± 0.07 | 0.12 ± 0.07 | 0.12 ± 0.08 | 0.92 |
zeaxanthin | 0.03 ± 0.01 | 0.03 ± 0.01 | 0.03 ± 0.02 | 0.30 | 0.03 ± 0.01 | 0.02 ± 0.01 | 0.03 ± 0.01 | 0.47 |
cis-lutein/zeaxanthin | 0.01 ± 0.01 | 0.01 ± 0.01 | 0.01 ± 0.01 | 0.59 | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.01 ± 0.01 | 0.07 |
cis-lycopene | 0.18 ± 0.13 | 0.18 ± 0.11 | 0.18 ± 0.15 | 0.94 | 0.17 ± 0.11 | 0.19 ± 0.10 | 0.15 ± 0.13 | 0.26 |
trans-lycopene | 0.19 ± 0.12 | 0.20 ± 0.11 | 0.19 ± 0.14 | 0.81 | 0.19 ± 0.11 | 0.22 ± 0.10 | 0.16 ± 0.12 | 0.12 |
Abbreviation: SD, standard deviation
P value comparing intervention and control groups based on Student's t-test